May
04
Q1 2020 Developments in Healthcare and Pharma Antitrust
12 PM EDT
This teleconference program will cover an update on the recent antitrust developments in the U.S. in the health care and pharmaceuticals industries for Q1 2021.
May
04
This teleconference program will cover an update on the recent antitrust developments in the U.S. in the health care and pharmaceuticals industries for Q1 2021.
Log In to view your rate
Unlock the discounted member rate
Join first as a member, and then purchase this product at special member pricing.
Moderator:
Speaker(s):
CLE: The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, audio recordings of this program will be available to Section members on the Committee Program Audio page.
Explore Antitrust Law Section benefits - Learn More or call (800) 285-2221.
60
Web
May 04, 2021
This teleconference program will cover an update on the recent antitrust developments in the U.S. in the health care and pharmaceuticals industries for Q1 2021.
Skadden Arps Et Al
Skadden Arps et al
Skadden Arps et al
Health Care and Pharmaceuticals Committee
Section of Antitrust Law
Publications | Book
Competition as Public Policy
Publications | Book
Intellectual Property and Antitrust Handbook, Second Edition
Publications | Book
Antitrust Issues in International Intellectual Property Licensing Transactions
Audio and Video | On-Demand CLE
COVID-19: How Antitrust Enforcers Are Responding to the Global Pandemic [CC]
Audio and Video | On-Demand CLE
Rethinking Our Approach to Civil Litigation: Proposed ABA Guidelines on the Use of Special Masters (On-Demand CLE)
Audio and Video | On-Demand CLE
Antitrust Update: DOJ New Compliance Policy and Amicus Program Explained (On-Demand CLE)